Testosterone cipionate (Depo-Testosterone) injections: Supply issue
Testosterone cipionate injections 100 mg per ml, 10 ml vial will be out of stock from late October 2021 until September 2022 (pharmacode: 741264)
Reason for the out of stock
Pfizer notified Pharmac of a supply interruption for their Depo-Testosterone injection. The interruption is caused by manufacturing constraints in the USA. The site that makes Depo-Testosterone is being used to make COVID-19 related products. This has meant that they have had to reduce the volume of other medicines they make at this site.
Pfizer have contacted clinicians and the market to advise them of this issue.
We understand that Depo-Testosterone will be unavailable between late October 2021 and September 2022.
We have received clinical advice that the other funded testosterone injections are suitable alternatives. You can see the funded testosterone injections on the Pharmaceutical Schedule.
People who receive Depo-Testosterone
If you currently receive testosterone cipionate injections, you will need to talk to your prescriber about which alternative treatment is best for you.
We know that changing treatments is not ideal. We are sorry about any inconvenience caused by this supply issue.
Who to contact
If you have any questions about Depo-Testosterone, call Pfizer Customer Services on 0800 736 363
If you receive Depo-Testosterone, talk to the person who prescribed the treatment. They know you and your clinical circumstances best and can advise on the best alternative for you.
If you have questions about the funding of testosterone injections, email firstname.lastname@example.org